T1	Participants 98 131	advanced myeloid leukemia and MDS
T2	Participants 254 306	acute myelogenous leukemia/myelodysplastic syndromes
T3	Participants 850 940	patients with myeloid leukemia undergoing allogeneic stem cell transplantation (allo-SCT).
T4	Participants 1323 1341	Fifty-one patients
T5	Participants 1406 1486	There were 32 males and 19 females, with a median age of 45 years (range: 6-59).
T6	Participants 2164 2228	Forty-one patients had active leukemia at the time of transplant
T7	Participants 2976 3004	high-risk patient population
